Short Interest Decreases By 19.4% For NXTM

The most recent short interest data has been released by the NASDAQ for the 04/30/2015 settlement date, which shows a 845,639 share decrease in total short interest for NxStage Medical Inc ( NXTM), to 3,522,966, a decrease of 19.36% since 04/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for NXTM at the 04/30/2015 settlement increased to 352,052, as compared to 329,973 at the 04/15/2015 report. That brought "days to cover" down to 10.01, a 24.41% decrease from the 13.24 days to cover calculated at the previous short interest data release.

The below chart shows the historical "days to cover" for NXTM at previous short interest release dates:

Top 25 S.A.F.E. Dividend Stocks »

A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where NXTM had been shorted as a hedge.

The chart below shows the one year performance of NXTM shares, versus its 200 day moving average. Looking at this chart, NXTM's low point in its 52 week range is $11.50 per share, with $19.63 as the 52 week high point — that compares with a last trade of $16.27.

If you liked this article you might like

Dow Scores Ninth Straight Record Close With Tiny Gains, S&P 500 at All-Time High

Dow Is Back on Track to Close at a Record High as Consumer Staples Lead

You Can't Force Action in an Environment Like This

Energy Losses Put Dow's Record-Breaking Streak in Jeopardy